Our ServicesChange Delivery
Mergers & Acquisitions
Our client, a well-known established brand in consumer goods, had grown significantly through an acquisition trail over a number of years. This left the organisation with a fragmented and ineffective enterprise application footprint. This footprint – a large number of disparate ERP and MES solutions – limited business operational efficiency and resulted in higher than industry standard operating cost.
What did Aveas do?
During the course of their global IT Operating Model and Technology review Aveas were asked to:
- review the enterprise application strategy and enterprise architecture operating model against good industry practice
- provide insight from similar organisations based on first-hand experience and research
- define the enterprise application operating principles for the future application strategy
- define the Target Operating Model for the Group IT Architecture function
- map the required business capabilities to the future recommended enterprise application model
- provide a roadmap to implement recommendations against findings
Our clients liked what we did too:
“The delivery of Target Operating Mode 2020 is going very well and it’s great to see how the function has transformed over the past 18 months. It is down to the initial analysis and solutioning that Aveas provided us that has put us on the right track.”
Chief Technology Officer – Global FMCG
What were the outcomes
Following senior management sign off (CIO, CTO, COO), Aveas were then asked to develop the detailed plan and collate the colleterial necessary for the retained organisation to deliver the roadmap which they continue to do.
With our experience, market insight and capabilities, and using our tools to help with deep analysis to overcome complexity, Aveas has provided this client with the capabilities to effectively delivery a robust future architecture operating model using their own resources. The roadmap will provide a number of years to implement given the scale of change required, but Aveas continue to provide some oversight when called upon.